⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for thyroid gland oncocytic carcinoma

Every month we try and update this database with for thyroid gland oncocytic carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid CancerNCT03914300
Differentiated ...
Follicular Vari...
Poorly Differen...
Refractory Diff...
Refractory Thyr...
Tall Cell Varia...
Thyroid Gland F...
Thyroid Gland O...
Thyroid Gland P...
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryNCT00381641
Differentiated ...
Recurrent Thyro...
Refractory Thyr...
Stage III Thyro...
Stage III Thyro...
Stage IV Thyroi...
Stage IV Thyroi...
Stage IV Thyroi...
Stage IVA Thyro...
Stage IVA Thyro...
Stage IVA Thyro...
Stage IVB Thyro...
Stage IVB Thyro...
Stage IVB Thyro...
Stage IVC Thyro...
Stage IVC Thyro...
Stage IVC Thyro...
Thyroid Gland O...
Unresectable Th...
Laboratory Biom...
Pharmacogenomic...
Sunitinib
Sunitinib Malat...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: